Article Listing - Eisai expecting major earnings leap

DRUGS AND SWEDEN'S HEALTH BILL

6 April 1992

Sales of pharmaceutical products in Sweden totaled 10 billion krone ($1.6 billion) in 1990, an increase of 1 billion krone...

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

Despite the enormous size of some Continental European pharmaceutical companies, they are being valued by their respective equity capital markets...

mexican health ministry merges

6 April 1992

In a major shake-up within the Mexican administration, the government is proposing to merge the Ministry of Health with the...

Hib VACCINE LAUNCHED IN FRANCE

6 April 1992

Pasteur Vaccins has launched HIbest, a Hemophilus influenzae type B conjugate vaccine, in France. The product is suitable for...

AUSTRALIAN PMA: MEG MIDDLETON

6 April 1992

Meg Middleton has been appointed public affairs manager for the Australian Pharmaceu-tical Manufacturers Associa-tion, in succession to Wendy Edwards.

APPOINTMENTS AT AKZO

6 April 1992

Akzo NV of the Netherlands has appointed Lodewijk van Wachem and Abraham Cohen as members of its supervisory board.

Italian Raw Materials Sales

6 April 1992

The Italian pharmaceutical raw materials market expanded by 8% in 1991 to 2,500 billion lire ($2.1 billion), according to the...

GERMAN COMPANIES REACT TO BKA WARNING

6 April 1992

Two leading German drug wholesalers, Gehe of Stuttgart and Sanacorp of Bavaria, have reacted sharply to the recent warning by...

SANOFI 1991 NET INCOME UP 12.1%

6 April 1992

For France's Elf Sanofi, earnings progressed satisfactorily in 1991 despite the adverse operating environment (the world economic situation including the...

DEPRESSION: THE COST TO SOCIETY

6 April 1992

The costs of depression to the National Health Service in the UK are L 333 million per year, according to...

Showing 94421-94430 of 95376 articles

Go to beginningPreviousNextGo to end